Navigation Links
Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects
Date:5/23/2013

(PRWEB) May 23, 2013

During pregnancy both the health of the mother and the growing fetus are affected by medical treatments, especially medication. In July 2006, a study published by the New England Journal of Medicine prompted the FDA to warn about a potential link between certain antidepressant drugs and serious birth defects such as persistent pulmonary hypertension and other malformations (i). The FDA specifically warned about selective serotonin reuptake inhibitor (SSRI) drugs. SSRI antidepressants are widely prescribed to treat conditions like anxiety, depression, and obsessive compulsive disorder. SSRI drugs include Celexa, Lexapro, Paxil, Prozac, and Zoloft. Prozac was the first on the market in 1987 and approval for other antidepressants followed shortly after.

Initially, the FDA was concerned about women who were pregnant or planning to become pregnant because the study published in the New England Journal of Medicine suggested that antidepressant use could pose a risk if taken during the early stages of pregnancy. The FDA’s concerns were validated by another study published in the same journal in June 2007. The study sampled 10,000 infants born with birth defects and approximately 6,000 healthy infants. Researchers found that women who took Zoloft (sertraline) in the early months of pregnancy had twice the risk of having a baby born with a heart defect. Additionally, women on Paxil (paroxetine) had over three times the risk (ii).

The FDA has since asked drug manufacturers like GlaxoSmithKline (GSK) to strengthen the warning of these antidepressants. According to a Bloomberg Report from July 2010, GSK has settled approximately 800 birth defect claims for an estimated $1 billion (iii). The antidepressant informational graphic describes this settlement as well as providing information on two medical studies. Find out more about the factors you should consider when taking antidepressants during pregnancy by visiting the antidepressant webpage and viewing the antidepressant infographic: Antidepressant Infographic.

If you or a loved one has taken antidepressants during pregnancy and delivered a child with birth defects such as persistent pulmonary hypertension, heart valve problems, or other malformations, you should find an experienced personal injury lawyer who can file an antidepressant lawsuit on your behalf. d’Oliveira & Associates is working with some of the more experienced antidepressant lawyers in the country who will work to help you obtain an antidepressant settlement or an award. Feel free to contact our law offices anytime at 1-800-992-6878.

Links:

(i) FDA Public Health Advisory, July 2006. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm124348.htm
(ii) US News Article, June 2007. http://health.usnews.com/usnews/health/articles/070627/27antidepressant.htm
(iii) Bloomberg Report, July 2010. http://www.bloomberg.com/news/2010-07-20/glaxo-said-to-have-paid-1-billion-to-resolve-paxil-birth-defect-lawsuits.html

Read the full story at http://www.prweb.com/releases/2013/5/prweb10763916.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury
2. Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event
3. Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier
4. Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries
5. Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center
6. Bedros Keuilian, Fitness Marketing Mastermind and Founder of PTPower.com, Reveals New Fitness Center Business Plan to Help Personal Trainers Wanting to Grow Their Fitness
7. Personal Injury Law Firm Helps New Bedford Man Recover $650,000 For Auto Accident Injuries
8. Atlanta Personal Injury Lawyer at Stokes & Kopitsky, P.A. Commends Plans to Make Streets Safer for Cyclists
9. Study supports alternative model for personality disorders in upcoming DSM-5
10. Brand id
11. Strategic Partners Hosts Monthly Workshop; Teaches Area Entrepreneurs To Own Their Personal Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... There are nearly 14.5 million people living with and ... On Sunday, June 5, 2016, communities around the world will gather to recognize these ... National Cancer Survivors Day® is an annual worldwide Celebration of Life that is held ...
(Date:5/26/2016)... ... 26, 2016 , ... In an effort to provide hair restoration information to the widest possible ... those who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair ... Live . , Dr. Mohebi says, “The positive response to the Snapchat videos we ...
(Date:5/26/2016)... ... May 26, 2016 , ... North Cypress Medical Center ... Blackhorse Golf Club in Cypress. With the help of community partners, the event organizers ... and renews hope for wounded service members and their families through health, wellness, and ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our professional ... TO YOUR HEAD ™”. , “We are proud to introduce Meghan Klingenberg, ... front we have Brian Quick, wide receiver for Los Angeles who was a second ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: